Last reviewed · How we verify
Magnesium glucoheptonate
Magnesium glucoheptonate is an oral magnesium supplement that provides bioavailable magnesium ions to correct magnesium deficiency and support normal cellular and enzymatic function.
Magnesium glucoheptonate is an oral magnesium supplement that provides bioavailable magnesium ions to correct magnesium deficiency and support normal cellular and enzymatic function. Used for Magnesium deficiency (hypomagnesemia), Magnesium supplementation for nutritional support.
At a glance
| Generic name | Magnesium glucoheptonate |
|---|---|
| Sponsor | Scarborough General Hospital |
| Drug class | Magnesium supplement |
| Modality | Small molecule |
| Therapeutic area | Nutritional/Metabolic |
| Phase | FDA-approved |
Mechanism of action
Magnesium glucoheptonate is a chelate complex of magnesium bound to glucoheptonic acid, designed to enhance magnesium absorption in the gastrointestinal tract. The glucoheptonate ligand facilitates intestinal uptake and bioavailability of magnesium, which is essential as a cofactor for over 300 enzymatic reactions including energy metabolism, protein synthesis, and neuromuscular function. It is used to treat or prevent magnesium deficiency states.
Approved indications
- Magnesium deficiency (hypomagnesemia)
- Magnesium supplementation for general health maintenance
Common side effects
- Diarrhea
- Gastrointestinal upset
- Nausea
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Magnesium glucoheptonate CI brief — competitive landscape report
- Magnesium glucoheptonate updates RSS · CI watch RSS
- Scarborough General Hospital portfolio CI